Literature DB >> 12024803

Effects of whole deletion of CYP2A6 on nicotine metabolism in humans.

X Zhang1, K Ameno, S Ameno, H Kinoshita, T Kubota, M Kumihashi, J Mostofa, K Iwahashi, I Ijiri.   

Abstract

We investigated the effects of CYP2A6 genotypes on nicotine metabolism, focused from nicotine to cotinine and its additional 3'-hydroxylating resulted in trans-3'-hydroxycotinine formation. In the subjects genotyped by PCR-RFLP method, one cigarette smoking experiment was performed and urine samples were collected for 24 h. In all subjects who smoked, we detected nicotine, cotinine and trans-3'-hydroxycotinine in urine by GC-MS analysis. In whole deletion of CYP2A6, urinary excretion amounts of cotinine and trans-3'-hydroxycotinine were significantly smaller than those in the wild-type of CYP2A6*1. A lack of CYP2A6 reduces the formation of cotinine and trans-3'-hydroxycotinine, but not entirely reduces the trans-3'-hydroxycotinine formation. Unknown cotinine 3'-hydroxylating activity except CYP2A6 are suspected in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024803     DOI: 10.1081/dct-120003260

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  6 in total

Review 1.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Authors:  Cheyenne E Allenby; Kelly A Boylan; Caryn Lerman; Mary Falcone
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-12       Impact factor: 4.147

2.  Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

Authors:  Sharon E Murphy
Journal:  Chem Res Toxicol       Date:  2016-11-22       Impact factor: 3.739

3.  The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.

Authors:  Joseph Bloom; Anthony L Hinrichs; Jen C Wang; Linda B von Weymarn; Evan D Kharasch; Laura J Bierut; Alison Goate; Sharon E Murphy
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

4.  Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.

Authors:  Sungshim L Park; Maarit I Tiirikainen; Yesha M Patel; Lynne R Wilkens; Daniel O Stram; Loic Le Marchand; Sharon E Murphy
Journal:  Carcinogenesis       Date:  2016-01-27       Impact factor: 4.944

5.  Nicotine mediated microcystic oedema in white matter of cerebellum: possible relationship to postural imbalance.

Authors:  Anshu Tewari; Mahdi Hasan; A Sahai; P K Sharma; A K Agarwal
Journal:  Ann Neurosci       Date:  2011-01

6.  Nicotine metabolism and its association with CYP2A6 genotype among Indigenous people in Alaska who smoke.

Authors:  Krista R Schaefer; Jaedon P Avey; Michael R Todd; Julie A Beans; Denise A Dillard; Laura M Shireman; Timothy A Thornton; Rachel F Tyndale; Kenneth E Thummel; Renee F Robinson; Katrina G Claw
Journal:  Clin Transl Sci       Date:  2021-09-14       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.